Literature DB >> 2427850

Beta adrenoceptor antagonists and respiratory disease.

A E Tattersfield.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427850     DOI: 10.1097/00005344-198608004-00007

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


× No keyword cloud information.
  7 in total

Review 1.  The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomes.

Authors:  J D Fitzgerald
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

Review 2.  Newer beta blockers and the treatment of hypertension.

Authors:  D McAreavey; R Vermeulen; J I Robertson
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

3.  Comparative effects of bisoprolol and acebutolol in smokers with airway obstruction.

Authors:  I Macquin-Mavier; F Roudot-Thoraval; C Clerici; C George; A Harf
Journal:  Br J Clin Pharmacol       Date:  1988-09       Impact factor: 4.335

4.  Respiratory function in the elderly and the effects of beta blockade.

Authors:  A E Tattersfield
Journal:  Cardiovasc Drugs Ther       Date:  1991-01       Impact factor: 3.727

Review 5.  Cardioselective beta-blockers for chronic obstructive pulmonary disease.

Authors:  S Salpeter; T Ormiston; E Salpeter
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

6.  Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.

Authors:  Qingxia Du; Yongchang Sun; Ning Ding; Lijin Lu; Ying Chen
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

Review 7.  Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions.

Authors:  Khaled Albouaini; Mohammed Andron; Albert Alahmar; Mohaned Egred
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.